SARS-CoV-2 collection

LATEST RESULTS: Visit our page dedicated to antiviral compounds test results against COVID19

Given the epidemiological situation concerning SARS-CoV-2, a simplified and faster procedure has been put in place for the supply of molecular diagnostics control and viral strains to the scientific community worldwide.

Here is the list of the available products on our website:

**Virus Products**
REF/SKU		Variant
005V-04479	SARS-CoV-2, Human, 2021, Slovenia, 21K/Omicron (B.1.1.529)	21K/Omicron (B.1.1.529)
014V-04473	SARS-CoV-2, strain hCOV-19/Curacao/CW-RIVM-35049/2021 , Mu variant, lineage B.1.621
001V-04469	SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2021/FR/X1 (Lineage B 1.617.2, Delta)	21A/Delta (B.1.617.2)
017V-04441	Human SARS-CoV-2 hCoV-19/France/PDL-IPP46934/2021, Omicron, lineage BA.1	21K/Omicron (B.1.1.529)
009V-04437	SARS-CoV-2, human, 2021, Germany, B.1.1.529, Omicron	21K/Omicron (B.1.1.529)
001V-04436	SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2021/FR/1514 (Lineage B 1.1.529, Omicron)	21K/Omicron (B.1.1.529)
014V-04430	SARS-CoV-2, strain hCoV-19/Netherlands/NH-RIVM-71076/2021, Omicron variant, lineage B.1.1.529	21K/Omicron (B.1.1.529)
014V-04429	SARS-CoV-2, strain hCoV-19/Netherlands/NH-RIVM-72291/2021, Omicron variant, lineage B.1.1.529	21K/Omicron (B.1.1.529)
010V-04425	SARS-CoV-2, strain hCoV-19/Netherlands/NH-EMC-1720/2021, Omicron variant, lineage B.1.1.529 - Calu 3 culture	21K/Omicron (B.1.1.529)
005V-04420	SARS-CoV-2, strain hCoV-19/Slovenia/410212/21 (lineage AY.4.2)	21A/Delta (B.1.617.2)
008V-04418	SARS-CoV-2, strain hCoV-19/Italy/LAZ-INMI-642isl/2021, clade G, lineage B.1.617.1, VUM (former VOI Kappa)	20A/452R (B.1.617)
008V-04417	SARS-CoV-2, strain hCoV-19/Italy/LAZ-INMI-494isl/2021, clade GH, lineage B.1.351.3, VOC Beta	20H/501Y.V2/Beta, V2 (B.1.351)
005V-04401	SARS-CoV-2, strain hCoV-19/Slovenia/296835/21 (lineage B.1.526)	20C/484K or 20C/477N (B.1.526)
017V-04400	Human 2019-nCoV - hCoV-19/France/HDF-IPP11602i/2021, clade 21A/B.1.617.2	21A/Delta (B.1.617.2)
005V-04398	SARS-CoV-2, strain hCoV-19/Slovenia/60296/21 (lineage C.16)	C.16 (B.1.1.1.16)
005V-04397	SARS-CoV-2, strain hCoV-19/Slovenia/308315/21 (lineage C.36.3)	C.36.3 (B.1.1.1.36.3)
005V-04396	SARS-CoV-2, strain hCoV-19/Slovenia/188058/21 (lineage B.1.617.1)
005V-04395	SARS-CoV-2, strain hCoV-19/Slovenia/292525/21 (lineage B.1.1.318)	20B/681H (B.1.1.318)
005V-04394	SARS-CoV-2, strain hCoV-19/Slovenia/20021/21 (lineage B.1.258.17)
006V-04329	SARS-CoV-2 strain Slovakia/SK-BMC-BA15/2021- B.1.617.2 variant (a.k.a. Delta VOC or "Indian variant")	21A/Delta (B.1.617.2)
001V-04282	SARS-CoV-2 virus, strain SARS-CoV-2/2021/FR/0610 (Lineage B 1.617.2, Delta)	21A/Delta (B.1.617.2)
014V-04279	SARS-CoV-2, strain hCoV-19/Netherlands/NH-RIVM-27142/2021, Delta variant, lineage B.1.617.2	21A/Delta (B.1.617.2)
014V-04278	SARS-CoV-2, strain hCoV-19/Netherlands/UT-RIVM-15598/2021, Eta variant, lineage B.1.525	20A/484K (B.1.525)
014V-04277	SARS-CoV-2, strain hCoV-19/St-Maarten/SX-RIVM-13806/2021, Iota variant, lineage B.1.526	20C/484K or 20C/477N (B.1.526)
014V-04276	SARS-CoV-2, strain hCoV-19/Netherlands/UT-RIVM-12844/2021, Alpha variant + E484K, nextstrain clade 20I/501Y.V1, lineage B.1.1.7	20I/484K or 484Q (B.1.1.7 + E484K/Q)
004V-04252	Human nCoV19 isolate/UK ex-India/HCM/V/078 SARS-CoV-2 (Lineage B.1.617.2)	21A/Delta (B.1.617.2)
005V-04249	SARS-CoV-2, Human, 2021, Slovenia ex India, 21A/478K.V1 (B.1.617.2, Delta)	21A/Delta (B.1.617.2)
005V-04248	SARS-CoV-2, Human, 2021, Slovenia ex imported, 20J/501Y.V3 (P.1)	20J/501Y.V3/Gamma, V3 (P.1)
017V-04219	SARS-CoV-2 isolate - hCoV-19/France/BRE-IPP04392/2021, clade 20C, lineage B.1.616	20C/655Y (B.1.616)
017V-04212	Human SARS-CoV-2 - hCoV-19/French Guiana/IPP03772/2021, lineage P.1	20J/501Y.V3/Gamma, V3 (P.1)
017V-04211	SARS-CoV-2 isolate - BetaCoV/Mayotte/IPP00884/2021, lineage A.27
012V-04195	SARS-CoV-2, hCoV-19/Sweden/21-51217/2021 (lineage B.1.351, ex South African variant)	20H/501Y.V2/Beta, V2 (B.1.351)
012V-04194	SARS-CoV-2, hCoV-19/Sweden/20-53840/2020 (lineage B 1. 1 .7, UK)	20I/501Y.V1/Alpha, V1 (B.1.1.7)
012V-04193	SARS-CoV-2, hCoV-19/Sweden/20-53787/2020 (lineage B 1. 1 .7, UK)	20I/501Y.V1/Alpha, V1 (B.1.1.7)
001V-04191	SARS-CoV-2 virus, strain SARS-CoV-2/2021/FR/4700 (lineage A27-like)
001V-04190	SARS-CoV-2 virus, strain SARS-CoV-2/2021/JP/TY7-503 (lineage P.1, ex Brazil)	20J/501Y.V3/Gamma, V3 (P.1)
001V-04189	SARS-CoV-2 virus, strain SARS-CoV-2/2021/JP/TY7-501 (lineage P.1, ex Brazil)	20J/501Y.V3/Gamma, V3 (P.1)
009V-04187	SARS-CoV-2, Human, 2021, Germany ex India, 20A/452R (B.1.617)	20A/452R (B.1.617)
008V-04186	SARS-CoV-2 variant G/484K.V3, isolate hCoV-19/Italy/LAZ-INMI-289/2021, clade G, Q52R, Δ69-70, Δ144, E484K, Q677H, F888L (S)
008V-04185	SARS-CoV-2 variant VOC 202012/01, isolate hCoV-19/Italy/LAZ-INMI-129isl/2020, clade GRY, Δ69-70, Δ144, N501Y, A570D, D614G, P681H, T716I (S)	20I/501Y.V1/Alpha, V1 (B.1.1.7)
006V-04183	SARS-CoV-2 strain Slovakia/SK-BMC-BA11/2021- B.1.351 variant (a.k.a. 20H/501Y.V2 or "South African variant")	20H/501Y.V2/Beta, V2 (B.1.351)
005V-04144	SARS-CoV-2, strain hCoV-19/Slovenia/65006/21 (A.27) (D796Y, G1219V, A653V, H655Y, N501Y)	19B/501Y (A.27)
005V-04110	SARS-CoV-2, strain hCoV-19/Slovenia/65882/21 (lineage A.27) (D796Y, G1219V, A653V, H655Y, N501Y)	19B/501Y (A.27)
005V-04109	SARS-CoV-2, strain hCoV-19/Slovenia/57573/21 (lineage B.1.525)	20A/484K (B.1.525)
005V-04107	SARS-CoV-2, strain hCoV-19/Slovenia/71693/21 (lineage B.1.351)	20H/501Y.V2/Beta, V2 (B.1.351)
008V-04101	SARS-CoV-2 variant GR/501Y.V3, isolate hCoV-19/Italy/LAZ-INMI-216isl/2021, clade GR, PANGO lineage P.1, K417T, E484K, N501Y (S)	20J/501Y.V3/Gamma, V3 (P.1)
014V-04092	SARS-CoV-2 virus, strain hCoV-19/Netherlands/Gelderland_20949/2021, N501T (S), nextstrain clade 20D, lineage C.2
014V-04091	SARS-CoV-2 virus, strain hCoV-19/Aruba_11401/2021, California variant, nextstrain clade CAL.20C, lineage B.1.429	20C/452R (B.1.427/ B.1.429)
014V-04090	SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordBrabant_10706/2021, Brazilian variant P.2, nextstrain clade 20B, lineage B.1.1.28 P.2
014V-04089	SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_10915/2021, Brazilian variant P.1, nextstrain clade 20J, lineage B.1.1.28 P.1
017V-04087	Human 2019-nCoV - hCoV-19/France/PDL-IPP01065/2021, clade 20H/501Y.V2	20H/501Y.V2/Beta, V2 (B.1.351)
006V-04083	SARS-CoV-2 strain Slovakia/SK-BMC-P1A/2021- B.1.1.7 variant (VOC 202012/01)	20I/501Y.V1/Alpha, V1 (B.1.1.7)
001V-04080	SARS-CoV-2 virus, isolate England/MIG457/2020 (lineage B.1.1.7)	20I/501Y.V1/Alpha, V1 (B.1.1.7)
004V-04071	Human nCoV19 isolate/England ex-SA/HCM002/2021 (lineage B.1.351)	20H/501Y.V2/Beta, V2 (B.1.351)
001V-04067	SARS-CoV-2, UVE/SARS-CoV-2/2021/FR/1299-ex SA (lineage B 1.351)	20H/501Y.V2/Beta, V2 (B.1.351)
014V-04058	SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_10159/2021, South African variant, nextstrain clade 20H, lineage B.1.351	20H/501Y.V2/Beta, V2 (B.1.351)
017V-04055	Human 2019-nCoV - hCoV-19/France/IDF-IPP11324/2020, clade 20I/501Y.V1	20I/501Y.V1/Alpha, V1 (B.1.1.7)
005V-04053	SARS-CoV-2, strain hCoV-19/Slovenia/11454/21 (lineage B 1.1.7, exUK)	20I/501Y.V1/Alpha, V1 (B.1.1.7)
012V-04052	SARS-CoV-2, hCoV-19/Sweden/20-53846/2020 (lineage B 1. 1 .7, UK)	20I/501Y.V1/Alpha, V1 (B.1.1.7)
008V-04050	SARS-CoV-2 variant VOC 202012/01, isolate hCoV-19/Italy/CAM-INMI-118isl/2020, clade GR, Δ69-70, Δ144, N501Y, A570D, D614G, P681H, T716I (S)
008V-04049	SARS-CoV-2 isolate hCoV-19/Italy/LAZ-INMI-115isl/2020, clade G, D69-70, D614G (S)
008V-04048	SARS-CoV-2 isolate hCoV-19/Italy/LAZ-INMI-82isl/2020, clade GV, A222V, D614G (S)
008V-04047	SARS-CoV-2 isolate hCoV-19/Italy/LAZ-INMI-24/2020, clade GH, D614G (S)
001V-04044	SARS-CoV-2, UVE/SARS-CoV-2/2021/FR/7b (lineage B 1. 1 .7, ex UK)	20I/501Y.V1/Alpha, V1 (B.1.1.7)
004V-04032	Human nCoV19 isolate/England/MIG457/2020 (lineage B.1.1.7)	20I/501Y.V1/Alpha, V1 (B.1.1.7)
014V-04031	SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_20432/2020, VOC 202012/01, nextstrain clade 20I/501Y.V1, lineage B.1.1.7	20I/501Y.V1/Alpha, V1 (B.1.1.7)
014V-04030	SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_10006/2020, Netherlands ex Iran
001V-04006	SARS-CoV-2 virus, strain UVE/SARS-CoV2/2020/FR/ISA_D614
008V-04005	SARS-CoV-2 isolate SARS-CoV-2/Human/ITA/PAVIA10734/2020, clade G, D614G (S)
008V-03992	SARS-CoV-2 isolate SARS-CoV-2/human/ITA/INMI4/2020, clade GR, D614G (S)
002V-03991	SARS-CoV-2 human/DEU/HH-1/2020
014V-03981	SARS-CoV-2 virus, hCoV-19/Netherlands/NoordBrabant_10003/2020, clade B, D614 (S)
006V-03971	SARS-CoV-2 strain Slovakia/SK-BMC6/2020
014V-03968	SARS-CoV-2 virus, strain hCoV-19/Netherlands/ZuidHolland_10004/2020, clade B1.1, D614G (S)
001V-03967	SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2020/FR/702
005V-03961	SARS-CoV-2 strain Slovenia/SI-4265/20, D614G
017V-03960	Human 2019-nCoV - hCoV-19/France/GE1973/2020, clade G, D614G (S)
006V-03937	SARS-CoV-2 strain Slovakia/SK-BMC5/2020 FD
006V-03933	SARS-CoV-2 strain Slovakia/SK-BMC5/2020
010V-03903	SARS-CoV-2 strain /NL/2020
008V-03893	Human 2019-nCoV strain 2019-nCoV/Italy-INMI1, clade V
014V-03890	SARS-CoV-2 isolate - BetaCoV/France/IDF0372/2020
026V-03883	Human 2019-nCoV Isolate

**Service Products**
REF/SKU		Variant
001S-04431	SARS-CoV-2 in vitro infection
003S-03900	SARS-CoV-2 diagnostic training
026S-03464	Rapid reverse genetic as ISA on SARS-COV
006S-03089	Access to the UNIBAS BSL-3 infrastructure with theoretical and practical introduction and hands-on project training. Includes training in biosafety and safe work with RG3 viral pathogens
014S-03059	Institut Pasteur Paris - Management of biosafety and biosecurity in BSL3 containment facilities. The access will comprise a detailed theoretical and, subject to availability, practical application of the biosafety and biosecurity management of BSL3 in Ins
001S-02899	Training course: Next Generation Sequencing training for Ion torrent S5 sequencing
001S-02696	Training course: Lyophilization as a convenient method for long-term preservation of virus strains and derived products such as inactivated quality controls
003S-02038	Access to virus whole genome sequencing service at APHA
007S-01703	Access to UL infrastructure
009S-01682	Access to the INMI BSL-3 infrastructures for theoretical and practical training on biosafety and techniques related to RG3 virus isolation
002S-01572	Access to BSL-4 laboratory
001S-EVA363	Strain isolation from clinical sample

**Protein Products**
REF/SKU		Variant
022P-04480	recombinant receptor-binding domain (RBD)-SD1_Omicron variant (aa319-591) of SARS-CoV-2 StrepTag/TwinStrep-Tag	21K/Omicron (B.1.1.529)
022P-04415	recombinant receptor-binding domain (RBD)-SD1_SARS-CoV-1 SpyTag/StrepTag (aa 306-577)
022P-04363	recombinant receptor-binding domain (RBD)-SD1_Delta variant (aa319-591) of SARS-CoV-2 StrepTag/TwinStrep-Tag
022P-04339	recombinant receptor-binding domain (RBD)-SD1_SARS-CoV-2 SpyTag/StrepTag (aa 319 – 591) mutations E484K-N501Y
022P-04338	recombinant receptor-binding domain (RBD)-SD1_SARS-CoV-2 SpyTag/StrepTag (aa 319 – 591) mutations L452R-N501Y
022P-04337	recombinant receptor-binding domain (RBD)-SD1_SARS-CoV-2 SpyTag/StrepTag (aa 319 – 591) mutation E484K
022P-04336	recombinant receptor-binding domain (RBD)-SD1_SARS-CoV-2 SpyTag/StrepTag (aa 319 – 591) mutation E484Q
022P-04335	recombinant receptor-binding domain (RBD)-SD1_SARS-CoV-2 SpyTag/StrepTag (aa 319 – 591) mutation S477N
022P-04334	recombinant receptor-binding domain (RBD)-SD1_SARS-CoV-2 SpyTag/StrepTag (aa 319 – 591) mutation T478K
022P-04333	recombinant receptor-binding domain (RBD)-SD1_SARS-CoV-2 SpyTag/StrepTag (aa 319 – 591) mutation L452R
022P-04332	recombinant receptor-binding domain (RBD)-SD1_SARS-CoV-2 SpyTag/StrepTag (aa 319 – 591) B.1.617.1 + B.1.617.3
022P-04308	recombinant receptor-binding domain (RBD)-SD1_Gamma variant (aa319-591) of SARS-CoV-2 StrepTag/TwinStrep-Tag
022P-04307	recombinant receptor-binding domain (RBD)-SD1_Beta variant (aa319-591) of SARS-CoV-2 StrepTag/TwinStrep-Tag
022P-04306	recombinant receptor-binding domain (RBD)-SD1_Alpha variant (aa319-591) of SARS-CoV-2 StrepTag/TwinStrep-Tag
022P-04134	recombinant S1 protein (S1, aa 17-685) of SARS-CoV-2 SpyTag/StrepTag, glycosylated
022P-04124	recombinant N-terminal domain (NTD, aa 17-304) of SARS-CoV-2 SpyTag/StrepTag, glycosylated
022P-03958	recombinant receptor-binding domain (RBD)-SD1 (aa319-591) of SARS-CoV-2 TwinStrep-Tag
100P-03957	CTD of the SARS-CoV-2 nucleoprotein
100P-03956	NTD of the SARS-CoV-2 nucleoprotein
022P-03940	recombinant receptor-binding domain (RBD) of SARS-CoV-2 HisTag

**Nucleic Acid Products**
REF/SKU		Variant
010N-04427	SARS-CoV-2, strain hCoV-19/Netherlands/NH-EMC-1720/2021, Omicron variant, lineage B.1.1.529 – RNA	21K/Omicron (B.1.1.529)
009N-04244	RNA SARS-CoV-2 strain B.1.617 (Germany ex India)	20A/452R (B.1.617)
001N-04192	RNA of UVE/SARS-CoV-2/2021/FR/1299-ex SA	20H/501Y.V2/Beta, V2 (B.1.351)
014N-04150	SARS-CoV-2 RNA, strain hCoV-19/Netherlands/NoordHolland_10915/2021, Brazilian variant P.1, nextstrain clade 20J, lineage B.1.1.28 P.1
014N-04149	SARS-CoV-2 RNA, strain hCoV-19/Netherlands/NoordBrabant_10706/2021, Brazilian variant P.2, nextstrain clade 20B, lineage B.1.1.28 P.2
014N-04148	SARS-CoV-2 RNA, strain hCoV-19/Netherlands/Gelderland_20949/2021, N501T (S), nextstrain clade 20D, lineage C.2
014N-04147	SARS-CoV-2 RNA, strain hCoV-19/Netherlands/NoordHolland_10159/2021, South African variant, nextstrain clade 20H, lineage B.1.351	20H/501Y.V2/Beta, V2 (B.1.351)
014N-04146	SARS-CoV-2 RNA, strain hCoV-19/Aruba_11401/2021, California variant, nextstrain clade CAL.20C, lineage B.1.429	20C/452R (B.1.427/ B.1.429)
005N-04125	SARS-CoV-2 RNA, strain hCoV-19/Slovenia/57573/21 (lineage B.1.525)	20A/484K (B.1.525)
005N-04108	SARS-CoV-2 RNA, strain hCoV-19/Slovenia/71693/21 (lineage B.1.351)	20H/501Y.V2/Beta, V2 (B.1.351)
005N-04054	SARS-CoV-2 RNA, strain hCoV-19/Slovenia/11454/21 (lineage B 1.1.7, exUK)	20I/501Y.V1/Alpha, V1 (B.1.1.7)
001N-04051	RNA of SARS-CoV-2/2021/FR/7b (lineage B 1. 1 .7, ex UK)	20I/501Y.V1/Alpha, V1 (B.1.1.7)
006N-03939	SARS-CoV-2 strain Slovakia/SK-BMC5/2020, cDNA
006N-03938	SARS-CoV-2 strain Slovakia/SK-BMC5/2020, RNA
003N-03901	Wuhan coronavirus 2019 RdRP gene control
008N-03894	Human 2019-nCoV strain 2019-nCoV/Italy-INMI1 RNA
026N-03889	Human 2019-nCoV RNA
011N-03868	Coronavirus RNA specificity panel
026N-03866	Wuhan coronavirus 2019 E gene control
004N-02005	SARS-CoV Frankfurt 1 RNA
004N-EVA1407	MERS-CoV (hCoV-EMC) 1A assay (confirmatory assay)
004N-EVA1386	MERS-CoV (hCoV-EMC) upstream E (upE) assay (screening assay)
004N-EVA254	SARS-CoVFrankfurt 1 Isolate (IVT RNA)

**Detection Kit Products**
REF/SKU		Variant
001K-04413	Encapsidated RNA corresponding to the 5' region on the Spike coding sequence from SARS-CoV-2 alpha variant	20I/501Y.V1/Alpha, V1 (B.1.1.7)
001K-04412	Encapsidated RNA corresponding to the 5' region on the Spike coding sequence from SARS-CoV-2 beta variant	20H/501Y.V2/Beta, V2 (B.1.351)
001K-04411	Encapsidated RNA corresponding to the 5' region on the Spike coding sequence from SARS-CoV-2 BavPat1 strain (D614G)
001K-04410	Encapsidated RNA corresponding to the 5' region on the Spike coding sequence from SARS-CoV-2 from SARS-CoV-2 delta variant	20A/452R (B.1.617)
001K-04409	Encapsidated RNA corresponding to the 5' region on the Spike coding sequence from SARS-CoV-2 gamma variant	20J/501Y.V3/Gamma, V3 (P.1)
001K-03964	Lyophilized Primers and Probe for RT-PCR in the SARS-CoV-2 N (CUB) gene
001K-03954	SARS-CoV-2 N (CUB) gene stabilized RNA as positive control: shipping at Room Temperature
001K-03952	Lyophilized Primers and Probe for RT-PCR in the SARS-CoV-2 RdRp (IP4) gene
001K-03934	SARS-CoV-2 RdRp (IP2/IP4) gene stabilized RNA as positive control: shipping at Room Temperature
012K-03928	SARS-CoV-2 (2019-nCoV) IF-slides
001K-03906	Lyophilized Primers and Probe for RT-PCR in the SARS-CoV-2 RdRp gene
001K-03905	SARS-CoV-2 RdRp gene stabilized RNA as positive control: shipping at Room Temperature
001K-03885	Lyophilized Primers and Probe for RT-PCR in the 2019-nCoV E gene
001K-03884	2019-nCoV E gene stabilized RNA as positive control: shipping at Room Temperature

**Bundle Products**
REF/SKU		Variant
001B-04287	Panel of SARS-CoV-2 variants	20I/501Y.V1/Alpha, V1 (B.1.1.7), 20H/501Y.V2/Beta, V2 (B.1.351), 20A/452R (B.1.617), 20J/501Y.V3/Gamma, V3 (P.1)
001B-03965	Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 N (CUB) gene, small packaging
001B-03955	Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 RdRp (IP4) gene, small packaging
001B-03929	Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 RdRp gene, medium packaging
001B-03907	Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 RdRp gene, small packaging
001B-03888	Primers, Probe and encapsidated RNA pos. control - 2019-nCoV E gene, Large packaging
001B-03887	Primers, Probe and encapsidated RNA pos. control - 2019-nCoV E gene, Medium packaging
001B-03886	Primers, Probe and encapsidated RNA pos. control - 2019-nCoV E gene, small packaging
100B-03867	Diagnostics controls for Wuhan coronavirus 2019 / 2019-nCoV

**Antibody or Hybridoma Products**
REF/SKU		Variant
024A-04304	SARS-CoV-2 Nucleocapsid protein monoclonal antibody
024A-04029	SARS-CoV-2 nucleoprotein antiserum
024A-04028	SARS-CoV-2 nucleoprotein antiserum
015A-01748	murine mAb: anti-Severe acute respiratory syndrome coronavirus NP (anti-SARS NP)

HOW TO RECEIVE FREE OF CHARGE SARS-CoV-2 diagnostics controls and viral strains:

Add only one SARS-CoV-2 related product at a time to your cart. Please note that for free of charge demands, only one product at a time should be ordered. If you want to request more than one product, simply place separate orders.
If you have more than one product in your cart, you won't be able to select the "free of charge option". This procedure is necessary to allow proper evaluation of your demand by our Selection Panel, and for transparency reasons towards the European Commission who will be sponsoring financially your access.
Create an account, or Log on to our portal
Fill in the required billing and shipping information, intended use, and technical description. Please indicate if you need an import permit in case you ordered the SARS RNA control product.
Don’t forget to tick the box for free of charge access
Accept the terms and conditions* (mandatory)
Complete you enquiry

Your enquiry will be forwarded to our Selection Panel that will evaluate your demand based on criteria defined in the European Commission specific provisions for transnational access activities guidelines.

This whole procedure will take less than 24h.

Once your enquiry is accepted, you will be put in contact with our EVA-GOBAL partner to arrange the shipment.

* May we bring your attention to clause 4 and 14 of EVA-GOBAL Terms and Conditions preventing redistribution of our products, and asking for citation of our organization in any publication resulting from the use of our products

LATEST RESULTS: Visit our page dedicated to antiviral compounds test results against COVID19

Comments (4)

Varsha Potdar
Log in or register to post comments
I applied online for the above mentioned positive control
National Institute of virology pune is WHO designated national Influenza centre and worked for public helath important viruses .
To have countries preparedness in place we required the positive control to set laboratory diagnosis

Jan 18, 2020

Isabelle Thomas
Log in or register to post comments
We would like to order this control free of charge, fir the NIC Belgium in order to perform diagnosis of the new coronavirus

Jan 20, 2020

K.Miyauchi
Log in or register to post comments
Thanks for these comments! Ordering these products is simple - we have described the process on this page under the title: HOW TO RECEIVE FREE OF CHARGE 2019-nCoV diagnostics controls.
This comments section is not regularly monitored, so if you have any urgent questions about the products or the ordering process I would encourage you to contact us through our contact page that is available from the header and the footer menus of this page.

Jan 23, 2020

RuoyuZhou
Log in or register to post comments
Hello,

We request for diagnostic purposes.
Our group is going to order the Coronavirus RNA specificity panel and the bundle of Wuhan coronavirus 2019 / 2019-nCoV Diagnositic control.
But for the import permit, can you offer more info about the RNA including Source and the method of purification?

Thank you very much.
Regards,
Ruoyu

Feb 27, 2020

EVAg